Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.33 -0.02 (-0.36%)
As of 09/17/2025 02:52 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.19 billion
P/E Ratio
22.81
Consensus Rating
Strong Buy
Volume
3,033 shares
Average Volume
48,384 shares
Today's Range
$4.32
$4.40
Senseonics stock logo

2. Senseonics NYSE:SENS

$0.45 0.00 (-0.36%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$0.45 +0.00 (+0.34%)
As of 09/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about Senseonics

Market Capitalization
$364.57 million
P/E Ratio
-3.44
Consensus Rating
Buy
Consensus Price Target
$1.54 (+243.6% Upside)
Volume
5.02 million shares
Average Volume
7.92 million shares
Ultrapar Participacoes stock logo

3. Ultrapar Participacoes NYSE:UGP

$3.95 +0.02 (+0.51%)
Closing price 09/17/2025 03:59 PM Eastern
Extended Trading
$3.95 0.00 (0.00%)
As of 09/17/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$4.38 billion
P/E Ratio
8.78
Consensus Rating
Buy
Consensus Price Target
$3.20 (-19.0% Downside)
Volume
1.84 million shares
Average Volume
1.46 million shares
TuHURA Biosciences stock logo

4. TuHURA Biosciences NASDAQ:HURA

$2.43 -0.05 (-2.02%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$2.51 +0.08 (+3.29%)
As of 09/17/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$124.12 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+421.3% Upside)
Volume
198,825 shares
Average Volume
236,332 shares
Today's Range
$2.43
$2.60
Climb Bio stock logo

5. Climb Bio NASDAQ:CLYM

$2.12 +0.11 (+5.47%)
As of 09/17/2025 04:00 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$136.21 million
P/E Ratio
-3.03
Consensus Rating
Buy
Consensus Price Target
$9.00 (+324.5% Upside)
Volume
567,871 shares
Average Volume
507,667 shares
Western Copper & Gold stock logo

6. Western Copper & Gold NYSE:WRN

$1.66 +0.01 (+0.61%)
As of 09/17/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$334.74 million
P/E Ratio
-83.00
Consensus Rating
Buy
Consensus Price Target
$4.00 (+141.0% Upside)
Volume
450,718 shares
Average Volume
390,072 shares
TriSalus Life Sciences stock logo

7. TriSalus Life Sciences NASDAQ:TLSI

$4.80 +0.07 (+1.48%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$4.80 0.00 (-0.10%)
As of 09/17/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$235.87 million
P/E Ratio
-4.07
Consensus Rating
Buy
Consensus Price Target
$10.90 (+127.1% Upside)
Volume
124,475 shares
Average Volume
95,027 shares
Hochschild Mining stock logo

8. Hochschild Mining OTCMKTS:HCHDF

$4.30 -0.09 (-1.98%)
As of 09/17/2025 03:57 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.26 billion
Consensus Rating
Buy
Volume
10,185 shares
Average Volume
40,761 shares
Today's Range
$4.24
$4.39
50-Day Range
$3.56
$4.70
FiscalNote stock logo

9. FiscalNote NYSE:NOTE

$4.40 +0.05 (+1.15%)
Closing price 09/17/2025 03:59 PM Eastern
Extended Trading
$4.52 +0.12 (+2.82%)
As of 09/17/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$62.40 million
P/E Ratio
-1.15
Consensus Rating
Buy
Consensus Price Target
$29.25 (+564.8% Upside)
Volume
163,735 shares
Average Volume
320,885 shares
Medicus Pharma stock logo

10. Medicus Pharma NASDAQ:MDCX

$2.41 -0.20 (-7.66%)
As of 09/17/2025 04:00 PM Eastern

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. More about Medicus Pharma

Market Capitalization
$46.50 million
P/E Ratio
-1.80
Consensus Rating
Buy
Consensus Price Target
$23.50 (+875.1% Upside)
Volume
428,867 shares
Average Volume
356,316 shares
zSpace stock logo

11. zSpace NASDAQ:ZSPC

$1.68 -0.08 (-4.55%)
As of 09/17/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$42.30 million
Consensus Rating
Buy
Consensus Price Target
$10.00 (+495.2% Upside)
Volume
89,617 shares
Average Volume
95,012 shares
Today's Range
$1.68
$1.85
Plus Therapeutics stock logo

12. Plus Therapeutics NASDAQ:PSTV

$0.42 -0.01 (-2.00%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$0.42 +0.00 (+0.82%)
As of 09/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus Therapeutics

Market Capitalization
$42.20 million
P/E Ratio
-0.19
Consensus Rating
Buy
Consensus Price Target
$7.88 (+1,790.3% Upside)
Volume
3.27 million shares
Average Volume
5.55 million shares
Mereo BioPharma Group stock logo

13. Mereo BioPharma Group NASDAQ:MREO

$1.73 -0.03 (-1.70%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$1.74 +0.02 (+0.87%)
As of 09/17/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$279.84 million
P/E Ratio
-24.71
Consensus Rating
Buy
Consensus Price Target
$7.40 (+327.7% Upside)
Volume
964,755 shares
Average Volume
892,334 shares
Stardust Power stock logo

14. Stardust Power NASDAQ:SDST

$2.90 +0.20 (+7.41%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$2.83 -0.07 (-2.55%)
As of 09/17/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$22.84 million
P/E Ratio
-0.52
Consensus Rating
Buy
Consensus Price Target
$51.13 (+1,662.9% Upside)
Volume
140,922 shares
Average Volume
119,712 shares
ImmunityBio stock logo

15. ImmunityBio NASDAQ:IBRX

$2.76 -0.05 (-1.78%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$2.79 +0.03 (+1.09%)
As of 09/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.66 billion
P/E Ratio
-5.75
Consensus Rating
Buy
Consensus Price Target
$10.75 (+289.5% Upside)
Volume
11.63 million shares
Average Volume
9.34 million shares
Ur Energy stock logo

16. Ur Energy NYSEAMERICAN:URG

$1.49 -0.01 (-0.67%)
Closing price 09/17/2025 04:10 PM Eastern
Extended Trading
$1.49 0.00 (0.00%)
As of 09/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$547.24 million
P/E Ratio
-8.76
Consensus Rating
Buy
Consensus Price Target
$2.48 (+66.1% Upside)
Volume
5.89 million shares
Average Volume
6.49 million shares
Perspective Therapeutics stock logo

17. Perspective Therapeutics NYSE:CATX

$3.04 -0.23 (-7.03%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$3.08 +0.04 (+1.48%)
As of 09/17/2025 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$225.76 million
Consensus Rating
Buy
Consensus Price Target
$12.56 (+313.0% Upside)
Volume
801,778 shares
Average Volume
921,335 shares
Today's Range
$3.02
$3.37
Quince Therapeutics stock logo

18. Quince Therapeutics NASDAQ:QNCX

$1.61 -0.01 (-0.62%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$1.64 +0.03 (+1.80%)
As of 09/17/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$87.02 million
P/E Ratio
-1.48
Consensus Rating
Buy
Consensus Price Target
$8.14 (+405.8% Upside)
Volume
142,360 shares
Average Volume
136,472 shares
Protara Therapeutics stock logo

19. Protara Therapeutics NASDAQ:TARA

$3.03 -0.04 (-1.30%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$3.04 +0.01 (+0.17%)
As of 09/17/2025 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Protara Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. More about Protara Therapeutics

Market Capitalization
$118.45 million
P/E Ratio
-1.87
Consensus Rating
Buy
Consensus Price Target
$19.60 (+546.9% Upside)
Volume
103,484 shares
Average Volume
139,845 shares
Biomea Fusion stock logo

20. Biomea Fusion NASDAQ:BMEA

$1.96 -0.06 (-2.97%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$2.02 +0.06 (+3.06%)
As of 09/17/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea Fusion

Market Capitalization
$120.21 million
P/E Ratio
-0.65
Consensus Rating
Buy
Consensus Price Target
$14.80 (+655.1% Upside)
Volume
667,515 shares
Average Volume
596,040 shares
Ovid Therapeutics stock logo

21. Ovid Therapeutics NASDAQ:OVID

$1.16 +0.02 (+1.75%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$1.17 +0.01 (+0.86%)
As of 09/17/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$81.07 million
P/E Ratio
-2.19
Consensus Rating
Buy
Consensus Price Target
$3.10 (+167.2% Upside)
Volume
928,460 shares
Average Volume
1.46 million shares
Nuvation Bio stock logo

22. Nuvation Bio NYSE:NUVB

$3.27 0.00 (0.00%)
Closing price 09/17/2025 03:59 PM Eastern
Extended Trading
$3.30 +0.02 (+0.76%)
As of 09/17/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$1.12 billion
P/E Ratio
-5.19
Consensus Rating
Buy
Consensus Price Target
$7.50 (+129.4% Upside)
Volume
4.94 million shares
Average Volume
6.53 million shares
PolyPid stock logo

23. PolyPid NASDAQ:PYPD

$3.37 -0.06 (-1.75%)
Closing price 09/17/2025 03:59 PM Eastern
Extended Trading
$3.40 +0.03 (+0.89%)
As of 09/17/2025 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. More about PolyPid

Market Capitalization
$54.53 million
P/E Ratio
-0.88
Consensus Rating
Buy
Consensus Price Target
$12.40 (+268.0% Upside)
Volume
20,012 shares
Average Volume
51,650 shares
Context Therapeutics stock logo

24. Context Therapeutics NASDAQ:CNTX

$0.88 +0.03 (+3.21%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$0.89 +0.02 (+1.71%)
As of 09/17/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$76.05 million
P/E Ratio
-2.43
Consensus Rating
Buy
Consensus Price Target
$5.25 (+500.0% Upside)
Volume
145,833 shares
Average Volume
82,788 shares
atai Life Sciences stock logo

25. atai Life Sciences NASDAQ:ATAI

$4.61 -0.04 (-0.86%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$4.64 +0.03 (+0.76%)
As of 09/17/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$996.67 million
P/E Ratio
-6.68
Consensus Rating
Buy
Consensus Price Target
$11.25 (+144.0% Upside)
Volume
2.94 million shares
Average Volume
4.56 million shares